UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 05,
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Cassava Sciences Charts.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Cassava Sciences Charts.

Cassava Sciences Inc News

Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
Wednesday 8 May 2024 (9 hours ago) • GlobeNewswire Inc.
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
Wednesday 1 May 2024 (1 week ago) • GlobeNewswire Inc.
Redemption Date Announced for Warrants
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
Monday 4 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
Wednesday 7 February 2024 (3 months ago) • GlobeNewswire Inc.
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Friday 26 January 2024 (3 months ago) • Edgar (US Regulatory)

More Cassava Sciences Inc News Articles